Literature DB >> 12379171

Hypertriglyceridemia and risk of coronary heart disease.

John E Hokanson1.   

Abstract

Mounting evidence indicates that elevated triglyceride level is a risk factor for coronary heart disease (CHD). The role of triglyceride as a causative agent for CHD is less clear. Hypertriglyceridemia is frequently associated with a set of complex metabolic abnormalities, including low high-density lipoprotein cholesterol, small dense low-density lipoprotein, central obesity, insulin resistance, and type 2 diabetes. Understanding the physiologic processes that lead to the metabolic disturbances associated with hypertriglyceridemia is essential in investigating the effect of triglyceride on CHD risk.

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12379171     DOI： 10.1007/s11886-002-0112-7

Source DB:  PubMed          Journal:  Curr Cardiol Rep        ISSN： 1523-3782            Impact factor:   2.931


  28 in total

1.  Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk.

Authors:  M A Austin; M C King; K M Vranizan; R M Krauss
Journal:  Circulation       Date:  1990-08       Impact factor: 29.690

2.  The serum lipoprotein transport system in health, metabolic disorders, atherosclerosis and coronary heart disease.

Authors:  John W Gofman; Oliver Delalla; Frank Glazier; Norman K Freeman; Frank T Lindgren; Alex V Nichols; Beverly Strisower; Arthur R Tamplin
Journal:  J Clin Lipidol       Date:  2007-05       Impact factor: 4.766

3.  Serum triglycerides in health and in ischemic heart disease.

Authors:  D F Brown; S H Kinch; J T Doyle
Journal:  N Engl J Med       Date:  1965-10-28       Impact factor: 91.245

4.  Serum triglycerides and risk of coronary heart disease among Japanese men and women.

Authors:  H Iso; Y Naito; S Sato; A Kitamura; T Okamura; T Sankai; T Shimamoto; M Iida; Y Komachi
Journal:  Am J Epidemiol       Date:  2001-03-01       Impact factor: 4.897

5.  Coronary heart disease prediction from lipoprotein cholesterol levels, triglycerides, lipoprotein(a), apolipoproteins A-I and B, and HDL density subfractions: The Atherosclerosis Risk in Communities (ARIC) Study.

Authors:  A R Sharrett; C M Ballantyne; S A Coady; G Heiss; P D Sorlie; D Catellier; W Patsch
Journal:  Circulation       Date:  2001-09-04       Impact factor: 29.690

Review 6.  The complex role of triglycerides in cardiovascular disease.

Authors:  Madiha F Abdel-Maksoud; John E Hokanson
Journal:  Semin Vasc Med       Date:  2002-08

7.  Linkage of low-density lipoprotein size to the lipoprotein lipase gene in heterozygous lipoprotein lipase deficiency.

Authors:  J E Hokanson; J D Brunzell; G P Jarvik; E M Wijsman; M A Austin
Journal:  Am J Hum Genet       Date:  1999-02       Impact factor: 11.025

8.  Plasma triglyceride level is a risk factor for cardiovascular disease independent of high-density lipoprotein cholesterol level: a meta-analysis of population-based prospective studies.

Authors:  J E Hokanson; M A Austin
Journal:  J Cardiovasc Risk       Date:  1996-04

9.  Epidemiology of triglycerides: a view from Framingham.

Authors:  W P Castelli
Journal:  Am J Cardiol       Date:  1992-12-14       Impact factor: 2.778

10.  Is the level of serum triglyceride a significant predictor of coronary death in "normocholesterolemic" subjects? The Paris Prospective Study.

Authors:  F Cambien; A Jacqueson; J L Richard; J M Warnet; P Ducimetiere; J R Claude
Journal:  Am J Epidemiol       Date:  1986-10       Impact factor: 4.897
View more
  10 in total

Review 1.  Overconsumption of dietary fat and alcohol: mechanisms involving lipids and hypothalamic peptides.

Authors:  Sarah F Leibowitz
Journal:  Physiol Behav       Date:  2007-03-30

Review 2.  Treatment of hypertriglyceridemia.

Authors:  Warren H Capell; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2006-06       Impact factor: 4.810

3.  Plasmapheresis for hypertriglyceridemia: The association between blood viscosity and triglyceride clearance rate.

Authors:  Hung-Chieh Wu; Lin-Chien Lee; Wei-Jie Wang
Journal:  J Clin Lab Anal       Date:  2018-10-15       Impact factor: 2.352

4.  Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study.

Authors:  D Dabelea; R B D'Agostino; C C Mason; N West; R F Hamman; E J Mayer-Davis; D Maahs; G Klingensmith; W C Knowler; K Nadeau
Journal:  Diabetologia       Date:  2010-10-01       Impact factor: 10.122

5.  Acetylator Genotype-Dependent Dyslipidemia in Rats Congenic for N-Acetyltransferase 2.

Authors:  Kyung U Hong; Mark A Doll; Angeliki Lykoudi; Raúl A Salazar-González; Mariam R Habil; Kennedy M Walls; Alaa F Bakr; Smita S Ghare; Shirish S Barve; Gavin E Arteel; David W Hein
Journal:  Toxicol Rep       Date:  2020-09-28

Review 6.  FoxO1 integrates insulin signaling to VLDL production.

Authors:  Adama Kamagate; H Henry Dong
Journal:  Cell Cycle       Date:  2008-10-27       Impact factor: 4.534

7.  Stearoyl-coenzyme A desaturase 1 deficiency protects against hypertriglyceridemia and increases plasma high-density lipoprotein cholesterol induced by liver X receptor activation.

Authors:  Kiki Chu; Makoto Miyazaki; Weng Chi Man; James M Ntambi
Journal:  Mol Cell Biol       Date:  2006-09       Impact factor: 4.272

8.  Artemisia Iwayomogi Extract Attenuates High-Fat Diet-Induced Hypertriglyceridemia in Mice: Potential Involvement of the Adiponectin-AMPK Pathway and Very Low Density Lipoprotein Assembly in the Liver.

Authors:  Jinhui Lee; Vikram P Narayan; Eun Young Hong; Wan Kyunn Whang; Taesun Park
Journal:  Int J Mol Sci       Date:  2017-08-12       Impact factor: 5.923

9.  A study on the relationship between waist phenotype, hypertriglyceridemia, coronary artery lesions and serum free fatty acids in adult and elderly patients with coronary diseases.

Authors:  Rui-Feng Yang; Hanlei Zhang; Zhongchun Wang; Xiao-Yong Liu; Zhi Lin
Journal:  Immun Ageing       Date:  2018-06-15       Impact factor: 6.400

Review 10.  Association between insulin resistance and the development of cardiovascular disease.

Authors:  Valeska Ormazabal; Soumyalekshmi Nair; Omar Elfeky; Claudio Aguayo; Carlos Salomon; Felipe A Zuñiga
Journal:  Cardiovasc Diabetol       Date:  2018-08-31       Impact factor: 9.951
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.